Insmed Incorporated

Historical 13F Holders

Symbol
INSM
CUSIP
457669307
All holders as of
Q2 2026
Type
Equity
Class
COM PAR $.01
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 457669307 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
7.4% 8/6/2026
Event 6/30/2026
BlackRock, Inc. 13G/A 6.6% 1/21/2026
Event 12/31/2025
Vanguard Capital Management LLC 13G 5.3% 4/30/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
JPMorgan Chase & Co 13G/A 4.7% 7/22/2026
Event 6/30/2026
Price T Rowe Associates Inc /MD/ 13G/A 3.3% 11/14/2025
Event 9/30/2025
Darwin Global Management, Ltd. 13G/A
3.0% 8/14/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 34 475 k $52.6 M
2026 Q2 725 257 M $24.2 B
2026 Q1 720 222 M $35.9 B
2025 Q4 743 219 M $38.0 B
2025 Q3 633 235 M $33.9 B
2025 Q2 573 215 M $21.6 B
2025 Q1 478 201 M $15.4 B
2024 Q4 492 193 M $13.3 B
2024 Q3 467 192 M $14.0 B
2024 Q2 448 180 M $12.0 B
2024 Q1 342 152 M $4.13 B
2023 Q4 302 153 M $4.75 B
2023 Q3 276 148 M $3.74 B
2023 Q2 239 146 M $3.09 B
2023 Q1 252 147 M $2.50 B
2022 Q4 241 151 M $3.01 B
2022 Q3 258 132 M $2.84 B
2022 Q2 224 130 M $2.56 B
2022 Q1 236 127 M $3.01 B
2021 Q4 229 124 M $3.37 B
2021 Q3 202 123 M $3.40 B
2021 Q2 216 122 M $3.47 B
2021 Q1 216 107 M $3.63 B
2020 Q4 227 108 M $3.58 B
2020 Q3 218 109 M $3.50 B
2020 Q2 213 111 M $3.06 B
2020 Q1 192 98.2 M $1.57 B
2019 Q4 199 99.7 M $2.38 B
2019 Q3 179 99.0 M $1.75 B
2019 Q2 206 127 M $3.25 B
2019 Q1 185 82.3 M $2.39 B
2018 Q4 150 83.3 M $1.09 B
2018 Q3 154 82.5 M $1.67 B
2018 Q2 144 82.8 M $1.96 B
2018 Q1 141 82.2 M $1.85 B
2017 Q4 142 75.9 M $2.37 B
2017 Q3 180 73.8 M $2.30 B
2017 Q2 130 56.5 M $970 M
2017 Q1 116 57.5 M $1.01 B
2016 Q4 109 58.3 M $772 M
2016 Q3 105 57.5 M $834 M
2016 Q2 119 56.5 M $557 M
2016 Q1 110 57.0 M $722 M
2015 Q4 128 57.3 M $1.04 B
2015 Q3 127 59.4 M $1.10 B
2015 Q2 121 54.5 M $1.33 B
2015 Q1 123 53.8 M $1.12 B
2014 Q4 100 42.2 M $657 M
2014 Q3 109 41.3 M $539 M
2014 Q2 117 31.6 M $630 M
2014 Q1 129 30.5 M $579 M